ChemAxon Kft:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ChemAxon Kft - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12111
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ハンガリー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ChemAxon Kft (ChemAxon) is a provider of software platforms. The company provides chemistry and biology software solutions and consultancy services that help in optimizing the value of chemistry information in life sciences and research and development. Its product portfolio consists of desktop and web applications; IT platform toolkit; discovery toolkit; chemistry text mining suite; Markush IP; and workflow, visualization and analysis software. ChemAxon also provides software solutions, applications and services to regulate cheminformatics, besides consultancy, training and hosted services. The company has business presence in the US, Europe, Japan, Korea, India, China, Malaysia, Singapore and Taiwan through subsidiaries and distributors. ChemAxon is headquartered in Budapest, Hungary.

ChemAxon Kft – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ChemAxon Kft, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ChemAxon Kft, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ChemAxon Kft, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ChemAxon Kft, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ChemAxon Kft, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ChemAxon Kft, Medical Equipment, Deal Details 10
Partnerships 10
Optibrium Enters into Technology Integration Agreement with ChemAxon 10
ChemAxon And Patcore Enter Into Distribution Agreement For Crais Product Series 11
TIBCO Software Enters Into Technology Integration Agreement With ChemAxon 12
ChemAxon Kft – Key Competitors 13
ChemAxon Kft – Key Employees 14
ChemAxon Kft – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Other Significant Developments 16
Dec 05, 2017: ChemAxon Software is Integrated into ChemPass’s Novel Drug Design Platform 16
Mar 08, 2017: ChemAxon Contributing to European Lead Factory’s Success 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
ChemAxon Kft, Medical Equipment, Key Facts 2
ChemAxon Kft, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ChemAxon Kft, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ChemAxon Kft, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ChemAxon Kft, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ChemAxon Kft, Deals By Market, 2012 to YTD 2018 8
ChemAxon Kft, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Optibrium Enters into Technology Integration Agreement with ChemAxon 10
ChemAxon And Patcore Enter Into Distribution Agreement For Crais Product Series 11
TIBCO Software Enters Into Technology Integration Agreement With ChemAxon 12
ChemAxon Kft, Key Competitors 13
ChemAxon Kft, Key Employees 14
ChemAxon Kft, Other Locations 15
ChemAxon Kft, Subsidiaries 15

List of Figures
ChemAxon Kft, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ChemAxon Kft, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ChemAxon Kft, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ChemAxon Kft, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ChemAxon Kft, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ChemAxon Kft, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ChemAxon Kft, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ChemAxon Kft, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ChemAxon Kft:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MedicPen AB (MPEN):医療機器:M&Aディール及び事業提携情報
    Summary MedicPen AB (MedicPen) is a drug development company that manufactures, develops, and markets patented products. The company’s products include Medimi Pro and Medimi Smart. It also provides Medimi – MedicPen’s system for medication assistance. MedicPen offers automatic filling units for home …
  • Southern Maryland Electric Cooperative Inc:企業の戦略的SWOT分析
    Southern Maryland Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Verisk Analytics, Inc.:戦略・SWOT・企業財務分析
    Verisk Analytics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Verisk Analytics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Oncolys BioPharma Inc (4588):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers and develops treatments for cancer and infectious diseases. The company import and export products including drugs and medicines, oncolytic viruses, pharmaceutical pipeline products and tumor diagnostic agents, among o …
  • Synthomer plc (SYNT):企業の財務・戦略的SWOT分析
    Synthomer plc (SYNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Prognomix Inc:企業の製品パイプライン分析
    Summary Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company’s products include PGX IR01, PGx GR01, PGx CD01, PGx IR02 …
  • Bet Shemesh Engines Holdings (1997) Ltd:企業の戦略・SWOT・財務分析
    Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report Summary Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • The Maryland Technology Development Corp:企業のM&A・事業提携・投資動向
    The Maryland Technology Development Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Maryland Technology Development Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • Seagate Technology Public Limited Company (STX):企業の財務・戦略的SWOT分析
    Seagate Technology Public Limited Company (STX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • IntriCon Corp (IIN):企業の財務・戦略的SWOT分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise value hearing health, biomedical solutions, hearing health manufacturing and professional audio. In addition it also …
  • Orliman SLU:医療機器:M&Aディール及び事業提携情報
    Summary Orliman SLU (Orliman), a subsidiary of The Riverside Company, is a medical device company that develops and manufactures orthopedic products. The company provides products such as stabilizers, immobilizers, lumbosacral back supports, abdominal bands, abdominal belt, shoulder supports, truss, …
  • L’Oreal USA, Inc.:企業の戦略的SWOT分析
    L'Oreal USA, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • National Petroleum Construction Co:企業の戦略・SWOT・財務情報
    National Petroleum Construction Co - Strategy, SWOT and Corporate Finance Report Summary National Petroleum Construction Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sysco Corporation (SYY):企業の財務・戦略的SWOT分析
    Sysco Corporation (SYY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • QHR Corporation:医療機器:M&Aディール及び事業提携情報
    Summary QHR Corporation (QHR), a subsidiary of Shoppers Drug Mart Inc. (SDMI), formerly known as QHR Technologies Inc., is a healthcare technology provider. It offers electronic medical records (EMR) for healthcare professionals including family physicians, medical specialists, and surgeons. The com …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ALS Therapy Development Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary ALS Therapy Development Institute (ALS TDI), formerly ALS Therapy Development Foundation, is a drug discovery center that offers research and healthcare services. The center's pipeline product include AT-1501, a novel antibody therapeutic that blocks specific immune cell activation and prote …
  • Elekeiroz SA (ELEK3):企業の財務・戦略的SWOT分析
    Elekeiroz SA (ELEK3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Promore Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Promore Pharma AB (Promore), formerly Pergamum AB is a biopharmaceutical company that develops peptide-based product candidates for local and topical treatment of infections and wounds. The company’s pipeline products include LL-37 and PXL01 therapeutic peptides. Its PXL01 is used for the pr …
  • ERG SpA (ERG)-エネルギー分野:企業M&A・提携分析
    Summary ERG S.p.A. (ERG), a subsidiary of San Quirico S.P.A., is a diversified energy company. Through its subsidiaries, it conducts power generation through renewable and thermal sources. The company carries out the distribution and marketing of petroleum products and conducts refining activities. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆